ArticleNeuro-oncology advances

A modified IRS-III chemotherapy regimen leads to prolonged survival in children with embryonal tumor with multilayer rosettes.

Derek Hanson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.